Drug-related violence: Will COVID-19 drive better data for safer and more secure EU?

Groshkova, Teodora; Liem, Marieke; Cunningham, Andrew; Sedefov, Roumen; Griffiths, Paul

Groshkova, Teodora; Liem, Marieke; Cunningham, Andrew; Sedefov, Roumen; Griffiths, Paul.

Groshkova T; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Praça Europa 1, Cais do Sodré, 1249-289 Lisbon, Portugal. Electronic address: teodora.groshkova@emcdda.europa.eu.
Liem M; Faculty Governance and Global Affairs, Leiden University, PO-Box 13228, 2501 EE The Hague, the Netherlands.
Cunningham A; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Praça Europa 1, Cais do Sodré, 1249-289 Lisbon, Portugal.
Sedefov R; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Praça Europa 1, Cais do Sodré, 1249-289 Lisbon, Portugal.
Griffiths P; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Praça Europa 1, Cais do Sodré, 1249-289 Lisbon, Portugal.

Int J Drug Policy ; 93: 103143, 2021 07.

Article in English | MEDLINE | ID: covidwho-1056547

Subject(s)

COVID-19; Pharmaceutical Preparations; Humans; SARS-CoV-2; Violence

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pharmaceutical Preparations / COVID-19 Limits: Humans Language: English Journal: Int J Drug Policy Journal subject: Public Health / Substance-Related Disorders Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google